Early-stage breast cancer: Update on management.

Advances in management of early-stage breast cancer include increasing use of neoadjuvant (presurgery) systemic therapy and oncoplastic surgical techniques in selected patients and the availability of new systemic therapies. These include targeted monoclonal antibody therapies, cyclin)dependent kinase 4/6 inhibitors, antibody-drug conjugates and immunotherapies. [ABSTRACT FROM AUTHOR]